Inventiva S.A. (IVA)
NASDAQ·Healthcare·Biotechnology
$3.50
-2.23%
Mkt Cap $331.65M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$15.80
Range $12.00 – $24.00
Implied Upside
+351.4%
Consensus $15.80 vs current $3.50
NASDAQ·Healthcare·Biotechnology
$3.50
-2.23%
Mkt Cap $331.65M
No recent rating data.
Price Target (7 analysts)
$15.80
Range $12.00 – $24.00
+351.4%
Consensus $15.80 vs current $3.50